www.fdanews.com/articles/147187-teva-pharma-to-present-data-from-studies-of-azilect-parkinson-rsquo-s-disease

Teva Pharma to Present Data From Studies of Azilect, Parkinson’s Disease

June 13, 2012

Teva Pharmaceutical Industries announced that data from studies of Azilect (rasagiline tablets) and Parkinson’s disease will be presented at the 16th Annual International Congress of Parkinson’s Disease and Movement Disorders in Dublin.
RTTNews